Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway

Inhibition of EGF-mediated ERK5 phosphorylation is examined for several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds.